Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2008-003840-13Phase 3Active
Phase 3, randomised, double-blind trial in tonsillitis and pharyngitis comparing Ibuprofen lozenge with Placebo lozenge (2 arms). Primary endpoint: Primary efficacy: reduction of pharyngeal pain at 1 hour. Started Sep 2008; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2008-003840-13.